SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-19-030096
Filing Date
2019-08-07
Accepted
2019-08-07 16:20:35
Documents
58
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q gwph-10q_20190630.htm   iXBRL 10-Q 1831595
2 EX-31.1 gwph-ex311_7.htm EX-31.1 16441
3 EX-31.2 gwph-ex312_10.htm EX-31.2 16478
4 EX-32.1 gwph-ex321_6.htm EX-32.1 6038
5 EX-32.2 gwph-ex322_8.htm EX-32.2 6130
  Complete submission text file 0001564590-19-030096.txt   5768600

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA gwph-20190630.xsd EX-101.SCH 36646
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE gwph-20190630_cal.xml EX-101.CAL 64693
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE gwph-20190630_def.xml EX-101.DEF 52371
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE gwph-20190630_lab.xml EX-101.LAB 274712
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE gwph-20190630_pre.xml EX-101.PRE 196695
11 EXTRACTED XBRL INSTANCE DOCUMENT gwph-10q_20190630_htm.xml XML 1037850
Mailing Address SOVEREIGN HOUSE VISION PARK HISTON, CAMBRIDGE CB24 9BZ X0 00000
Business Address SOVEREIGN HOUSE VISION PARK HISTON, CAMBRIDGE CB24 9BZ X0 00000 44 1223 266800
GW PHARMACEUTICALS PLC (Filer) CIK: 0001351288 (see all company filings)

IRS No.: 000000000
Type: 10-Q | Act: 34 | File No.: 001-35892 | Film No.: 191005784
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences